City Holding Co. Lowers Holdings in Colgate-Palmolive (NYSE:CL)

City Holding Co. lowered its position in Colgate-Palmolive (NYSE:CL) by 2.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,337 shares of the company’s stock after selling 210 shares during the quarter. City Holding Co.’s holdings in Colgate-Palmolive were worth $762,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Regal Investment Advisors LLC lifted its position in Colgate-Palmolive by 1.6% during the fourth quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock valued at $604,000 after purchasing an additional 121 shares during the last quarter. Cresset Asset Management LLC lifted its holdings in shares of Colgate-Palmolive by 8.1% during the 4th quarter. Cresset Asset Management LLC now owns 123,837 shares of the company’s stock worth $9,871,000 after acquiring an additional 9,231 shares during the last quarter. Ethic Inc. grew its position in Colgate-Palmolive by 20.6% in the fourth quarter. Ethic Inc. now owns 100,632 shares of the company’s stock worth $8,021,000 after acquiring an additional 17,170 shares in the last quarter. First Financial Bankshares Inc bought a new position in Colgate-Palmolive in the fourth quarter valued at $857,000. Finally, LM Advisors LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $319,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Activity

In related news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock worth $4,486,063 in the last quarter. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $100.98 on Thursday. The company has a market cap of $82.85 billion, a PE ratio of 31.96, a P/E/G ratio of 3.62 and a beta of 0.40. The business has a 50 day moving average of $103.61 and a 200 day moving average of $97.02. Colgate-Palmolive has a 52 week low of $68.54 and a 52 week high of $109.30. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. During the same period last year, the company posted $0.77 EPS. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.98%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on CL shares. Evercore ISI upped their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Stifel Nicolaus lifted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, July 22nd. Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $104.74.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.